Literature DB >> 30712253

Massive generalized crystal-storing histiocytosis associated with extracellular crystalline nephropathy: clinical, immunohistochemical, and ultrastructural studies of a unique disorder and review of the literature.

Fransico Galeano-Valle1,2, F J Díaz-Crespo3, R Melero-Martín4, J E Apaza-Chávez3, J Del-Toro-Cervera5,6, P Demelo-Rodríguez5,6.   

Abstract

Crystal-storing histiocytosis (CSH) is a rare disorder characterized by the accumulation of nonneoplastic histiocytes containing intracytoplasmic crystallized immunoglobulins. In most cases, there is an associated underlying lymphoplasmacytic neoplasm expressing Ig kappa light chain. About 131 cases of CSH have been identified. There is a localized and a generalized form of CSH and it can involve several sites including bone marrow, lungs, lymph nodes, liver, spleen, gastrointestinal tract, and kidney. Generalized CSH is less frequent and involves multiple organs and tends to have a worst prognosis than localized CSH. Around 20 cases of renal involvement in CSH have been reported so far. Paraprotein-induced crystalline nephropathy can be divided into two categories based on whether the crystals in the kidney are intracellular (including light chain proximal tubulopathy with crystals and CSH) or extracellular (including the crystalline variant of myeloma cast nephropathy and crystalglobulin-induced nephropathy). The former tends to present with slowly worsening kidney dysfunction and generally has a good prognosis, whereas the latter usually presents with rapidly progressive renal failure and is associated with poor renal outcome. We present a case of generalized CSH associated with extracellular crystalline nephropathy with a fulminant and fatal clinical course. Kappa light-chain crystals were found exclusively extracellularly within the tubular lumen, not within the tubular epithelial cells nor the histiocytes, and the massive presence of those precipitates led to the acute renal failure. Consequently, we review the renal involvement in CSH in the literature and discuss the unique mechanism of renal injury in this case.

Entities:  

Keywords:  Crystal-storing histiocytosis; Crystalline nephropathy; Histiocytes; Kappa light chains; Kidney

Mesh:

Year:  2019        PMID: 30712253      PMCID: PMC6620229          DOI: 10.1007/s13730-019-00385-5

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  13 in total

Review 1.  Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification.

Authors:  Snjezana Dogan; Leon Barnes; Wilhelmina P Cruz-Vetrano
Journal:  Head Neck Pathol       Date:  2012-03-20

2.  Pseudo-Gaucher cell in IgMk plasmacytoid lymphoma.

Authors:  C Padmalatha; T F Warner; G R Hafez
Journal:  Am J Surg Pathol       Date:  1981-07       Impact factor: 6.394

3.  Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain.

Authors:  D Jones; V K Bhatia; T Krausz; G S Pinkus
Journal:  Hum Pathol       Date:  1999-12       Impact factor: 3.466

4.  Crystal-storing histiocytosis: a clinicopathological study of 13 cases.

Authors:  Rashmi Kanagal-Shamanna; Zijun Y Xu-Monette; Roberto N Miranda; Ahmet Dogan; Dehui Zou; Rajyalakshmi Luthra; Donna M Weber; Dennis P O'Malley; Jeffrey L Jorgensen; Joseph D Khoury; Carlos E Bueso-Ramos; Robert Z Orlowski; L Jeffrey Medeiros; Ken H Young
Journal:  Histopathology       Date:  2015-08-27       Impact factor: 5.087

5.  Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder.

Authors:  Sanjeev Sethi; Barry P Cuiffo; Geraldine S Pinkus; Helmut G Rennke
Journal:  Am J Kidney Dis       Date:  2002-01       Impact factor: 8.860

6.  Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature.

Authors:  Annette Lebeau; Evelyn Zeindl-Eberhart; Eva-Christina Müller; Josef Müller-Höcker; Peter Roman Jungblut; Bertold Emmerich; Udo Löhrs
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

7.  Crystal-storing histiocytosis associated with lymphoplasmacytic neoplasms. Report of three cases mimicking adult rhabdomyoma.

Authors:  S B Kapadia; F M Enzinger; D K Heffner; V J Hyams; G Frizzera
Journal:  Am J Surg Pathol       Date:  1993-05       Impact factor: 6.394

8.  Crystalglobulin-induced nephropathy.

Authors:  Vinay Gupta; Mireille El Ters; Kianoush Kashani; Nelson Leung; Samih H Nasr
Journal:  J Am Soc Nephrol       Date:  2014-09-04       Impact factor: 10.121

Review 9.  Crystal-Storing Histiocytosis in Bone Marrow: A Clinicopathologic Study of Eight Cases and Review of the Literature.

Authors:  Hong Fang; April Chiu; Kaaren K Reichard
Journal:  Am J Clin Pathol       Date:  2018-01-29       Impact factor: 2.493

10.  Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.

Authors:  Chung-Kuan Wu; An-Hang Yang; Hung-Chih Lai; Bing-Shi Lin
Journal:  BMC Nephrol       Date:  2017-05-25       Impact factor: 2.388

View more
  3 in total

Review 1.  Immunoglobulin-Storing Histiocytosis: A Case Based Systemic Review.

Authors:  Hanne Wiese-Hansen; Friedemann Leh; Anette Lodvir Hemsing; Håkon Reikvam
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

2.  Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery.

Authors:  Angela Chou; Christopher Long; Leon Vonthethoff; Shir-Jing Ho; Franziska Pettit; Sunil V Badve
Journal:  Can J Kidney Health Dis       Date:  2020-05-18

Review 3.  A colonic mass revealing a disseminated crystal storing histiocytosis secondary to indolent multiple myeloma: a case report with literature review.

Authors:  Adrien Contejean; Frédérique Larousserie; Didier Bouscary; Anthony Dohan; Bénédicte Deau-Fischer; Tali-Anne Szwebel; Marion Dhooge; Benoit Terris; Marguerite Vignon
Journal:  BMC Gastroenterol       Date:  2020-07-31       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.